Novogene Past Earnings Performance

Past criteria checks 2/6

Novogene has been growing earnings at an average annual rate of 20.1%, while the Life Sciences industry saw earnings growing at 17.2% annually. Revenues have been growing at an average rate of 8.1% per year. Novogene's return on equity is 7.9%, and it has net margins of 8.9%.

Key information

20.1%

Earnings growth rate

17.8%

EPS growth rate

Life Sciences Industry Growth26.8%
Revenue growth rate8.1%
Return on equity7.9%
Net Margin8.9%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Earnings Working Against Novogene Co., Ltd.'s (SHSE:688315) Share Price

Sep 27
Earnings Working Against Novogene Co., Ltd.'s (SHSE:688315) Share Price

Some Confidence Is Lacking In Novogene Co., Ltd. (SHSE:688315) As Shares Slide 26%

Jun 07
Some Confidence Is Lacking In Novogene Co., Ltd. (SHSE:688315) As Shares Slide 26%

Time To Worry? Analysts Are Downgrading Their Novogene Co., Ltd. (SHSE:688315) Outlook

Apr 17
Time To Worry? Analysts Are Downgrading Their Novogene Co., Ltd. (SHSE:688315) Outlook

Estimating The Fair Value Of Novogene Co., Ltd. (SHSE:688315)

Mar 25
Estimating The Fair Value Of Novogene Co., Ltd. (SHSE:688315)

Revenue & Expenses Breakdown

How Novogene makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SHSE:688315 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 242,092187599110
30 Jun 242,069181593120
31 Mar 242,030183587123
31 Dec 232,002178572124
30 Sep 231,990190546129
30 Jun 232,006196550126
31 Mar 231,980181541126
31 Dec 221,926177531126
30 Sep 221,955209530138
30 Jun 221,914200505143
31 Mar 221,888211465139
31 Dec 211,866225444145
30 Sep 211,812218415129
30 Jun 211,707193382113
31 Mar 211,633132380115
31 Dec 201,49037369112
30 Sep 201,437-10374125
30 Jun 201,5509397143
31 Mar 201,47237380134
31 Dec 191,535114366126
30 Sep 191,377107342105
30 Jun 191,21910031885
31 Mar 191,1379929582
31 Dec 181,0549727279
31 Dec 177398120950
31 Dec 164583914431
31 Dec 15310258645

Quality Earnings: 688315 has high quality earnings.

Growing Profit Margin: 688315's current net profit margins (8.9%) are lower than last year (9.5%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 688315's earnings have grown significantly by 20.1% per year over the past 5 years.

Accelerating Growth: 688315's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 688315 had negative earnings growth (-1.3%) over the past year, making it difficult to compare to the Life Sciences industry average (-14.4%).


Return on Equity

High ROE: 688315's Return on Equity (7.9%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies